2020
DOI: 10.4103/japtr.japtr_17_20
|View full text |Cite
|
Sign up to set email alerts
|

Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 5 publications
0
5
0
Order By: Relevance
“…was detected in the sputum sample had higher odds of poor response to an antibiotic trial, even after adjusting for patient characteristics. This may be due to the presence of drug-resistant bacteria ( 32 ). Three of the four pathogens associated with failure to improve on an antibiotic trial were also associated with an increased odds of mortality in the 6 months following the initial assessment: S. pneumoniae/pseudopneumoniae (aOR 5.31, 95% CI 1.29–26.6), M. catarrhalis/nonliquefaciens (aOR 12.1, 95% CI 2.67–72.8), and M. pneumoniae (aOR 34.5 95% CI 4.79–292.3).…”
Section: Discussionmentioning
confidence: 99%
“…was detected in the sputum sample had higher odds of poor response to an antibiotic trial, even after adjusting for patient characteristics. This may be due to the presence of drug-resistant bacteria ( 32 ). Three of the four pathogens associated with failure to improve on an antibiotic trial were also associated with an increased odds of mortality in the 6 months following the initial assessment: S. pneumoniae/pseudopneumoniae (aOR 5.31, 95% CI 1.29–26.6), M. catarrhalis/nonliquefaciens (aOR 12.1, 95% CI 2.67–72.8), and M. pneumoniae (aOR 34.5 95% CI 4.79–292.3).…”
Section: Discussionmentioning
confidence: 99%
“…Drug resistance has also emerged in the treatment of respiratory infections. In a recent study, the group of Sediana showed that in the treatment of respiratory infections with levofloxacin, 50% of 142 patients had high levels of resistance, 30.95% had intermediate levels of resistance, and 19.04% of patients were still sensitive to the antibiotic [ 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…The study reported by Ramdhani et al, regarding the management of ARTIs patients in a public health center of Tasikmalaya, Indonesia, described a fairly serious case of antibiotic resistance. The use of several antibiotics showed decreased effectiveness with a high resistance value, including amoxicillin (70.25%), levofloxacin (50.0%), ciprofloxacin (43.03%) 11 – 13 .…”
Section: Introductionmentioning
confidence: 99%